PTC THERAPEUTICS, INC. (PTCT) › Operating Cash FlowPTC THERAPEUTICS, INC. (PTCT) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2014: -$57.27M2015: -$124.34M2016: -$103.57M2017: -$10.06M2018: -$27.64M2019: -$98.64M2020: -$194.07M2021: -$251.33M2022: -$356.65M2023: -$158.42M2024: -$107.69M2025: $711.20M$711.20M2014Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$711.20M+760.4%2024-$107.69M+32.0%2023-$158.42M+55.6%2022-$356.65M-41.9%2021-$251.33M-29.5%2020-$194.07M-96.7%2019-$98.64M-256.9%2018-$27.64M-174.7%2017-$10.06M+90.3%2016-$103.57M+16.7%2015-$124.34M-117.1%2014-$57.27M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share